A 24-Week Safety and Pharmacodynamic Study of AT1001 in Patients With Fabry Disease

Mise à jour : Il y a 5 ans
Référence : NCT00283933

Extrait

The purpose of this study is to collect information on the safety of AT1001 (migalastat hydrochloride) and how AT1001 works in patients with Fabry disease.


Critère d'inclusion

  • Fabry Disease

Liens